Invesco’s Niagen Bioscience NAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$192K Sell
43,487
-154
-0.4% -$831 ﹤0.01% 3495
2025
Q4
$278K Buy
43,641
+9,688
+29% +$67.4K ﹤0.01% 3414
2025
Q3
$317K Sell
33,953
-433,256
-93% -$4.37M ﹤0.01% 3397
2025
Q2
$6.73M Buy
467,209
+100,559
+27% +$993K ﹤0.01% 2026
2025
Q1
$2.53M Buy
366,650
+336,422
+1,113% +$2.11M ﹤0.01% 2449
2024
Q4
$160K Sell
30,228
-6,481
-18% -$35.5K ﹤0.01% 3551
2024
Q3
$134K Sell
36,709
-53,010
-59% -$167K ﹤0.01% 3579
2024
Q2
$245K Buy
+89,719
New +$300K ﹤0.01% 3556
2022
Q2
Sell
-15,789
Closed -$39K 4173
2022
Q1
$39K Sell
15,789
-390
-2% -$1.07K ﹤0.01% 3950
2021
Q4
$61K Sell
16,179
-468
-3% -$2.53K ﹤0.01% 3960
2021
Q3
$104K Buy
16,647
+4,094
+33% +$33.7K ﹤0.01% 3935
2021
Q2
$124K Sell
12,553
-799,151
-98% -$6.97M ﹤0.01% 3864
2021
Q1
$7.58M Buy
+811,704
New +$6.43M ﹤0.01% 2134
2019
Q2
Sell
-67,207
Closed -$282K 3794
2019
Q1
$282K Buy
67,207
+5,630
+9% +$20.3K ﹤0.01% 3508
2018
Q4
$211K Sell
61,577
-15,892
-21% -$55.2K ﹤0.01% 3546
2018
Q3
$332K Buy
77,469
+17,871
+30% +$76.8K ﹤0.01% 3578
2018
Q2
$221K Sell
59,598
-112,504
-65% -$427K ﹤0.01% 3675
2018
Q1
$723K Buy
+172,102
New +$901K ﹤0.01% 3185
2017
Q2
Sell
-22,638
Closed -$61K 3728
2017
Q1
$61K Buy
22,638
+2,865
+14% +$8.13K ﹤0.01% 3677
2016
Q4
$65K Buy
19,773
+526
+3% +$1.43K ﹤0.01% 3636
2016
Q3
$57K Buy
19,247
+394
+2% +$1.45K ﹤0.01% 3617
2016
Q2
$78K Buy
+18,853
New +$89.2K ﹤0.01% 3637

Other funds holding NAGE